Regulatory troubles continue for Sun Pharma as the drug manufacturer’s ... Analysts at HSBC expect the FDA move to add to the regulatory overhang for the drugmaker, while those at Nomura ...

The US Food and Drug Administration (US FDA) has released a detailed report ... the regulator to achieve fully compliant status,” Sun Pharma had informed exchanges on the matter on April 11.

New Delhi: On 18 April, Mumbai-headquartered Marksans Pharma, a drugmaker that ... from ThePrint on the status of this alert, the US FDA said that “in order for FDA to consider removing a product ...

Sun Pharma Q3 results today: What to expect from India’s top ... The company’s Halol plant, receiving an import alert from the USFDA earlier in December, remains a challenge for Sun. The earnings ...

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app. Pick your 5 favourite companies, get a daily email with all news updates on them. Full access to our ...

Sun Pharma said that the US FDA conducted an inspection at the company's Dadra facility from December 4, 2023 to December 15, 2023. The US FDA has subsequently determined the inspection ...

The Food and Drug Administration published an expanded import alert Wednesday to stop all plastic syringes made by a Chinese manufacturer from entering the U.S. On March 28, the FDA issued an ...

The Food and Drug Administration published an expanded import alert Wednesday to stop all plastic syringes made by a Chinese manufacturer from entering the U.S. On March 28, the FDA issued an ...

Medtech startup EzeRx Health Tech Pvt Ltd, which counts drugmaker Sun Pharma as its largest investor, is in talks with at least two venture capital firms and a state-run company to raise fresh equity ...

Mumbai-based pharmaceutical company, Sun Pharma Advanced Research Company Ltd. (SPARC), said it was abandoning its Phase 2 study on Vodobatinib for Parkinson's. The study was designed to evaluate ...